Thermo Fisher Scientific Inc. unveiled the Thermo Scientific Stellar mass spectrometer (MS).
The Stellar MS complements the Thermo Scientific Orbitrap Astral MS. The Orbitrap Astral MS is ideal for discovering new biomarkers and the Stellar MS connects these discoveries to clinical research, providing verification of biomarkers including peptides, metabolites, and lipids.
This workflow includes third-party software support via Thermo Scientific Ardia platform and high throughput liquid chromatography separation with the Thermo Scientific Vanquish Neo ultra-high performance liquid chromatography (UHPLC) system Tandem Direct Injection workflow, enabling time savings.
Thermo Fisher will showcase the Stellar MS at the American Society for Mass Spectrometry (ASMS) annual conference from June 2-6, 2024, in Anaheim, California. The Stellar and Orbitrap Astral mass spectrometers, together with additional new products being introduced at ASMS, will be on display.
For more information, please visit www.thermofisher.com/ASMS.